Can glucagon be used to reverse beta blocker (beta-adrenergic blocking agent) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Glucagon can be used to reverse beta blocker overdose, though it's considered a second-line treatment. In beta blocker poisoning, intravenous glucagon is typically administered as a 5-10 mg bolus over 1-2 minutes, followed by an infusion of 1-5 mg/hour titrated to clinical response 1. This approach works because glucagon activates adenylyl cyclase through a G-protein coupled receptor that bypasses the blocked beta receptors, thereby increasing intracellular cAMP levels and improving cardiac contractility and heart rate.

Key Points to Consider

  • Glucagon is particularly useful when the patient shows signs of cardiovascular compromise such as hypotension and bradycardia that hasn't responded to initial treatments like IV fluids and atropine.
  • First-line treatments for severe beta blocker overdose now typically include high-dose insulin therapy and vasopressors, with glucagon serving as an adjunctive therapy 1.
  • Clinicians should be prepared for the possibility that large doses may be required, and should ensure adequate airway protection as vomiting is a common side effect.
  • The recommended dose of glucagon is a bolus of 3 to 10 mg, administered slowly over 3 to 5 minutes, followed by an infusion of 3 to 5 mg/h 1.

Limitations and Side Effects

  • Glucagon has limitations including a short duration of action, potential for tachyphylaxis, and side effects like vomiting.
  • The amount of glucagon required to sustain this therapy may exceed 100 mg in a 24-hour period, plans should be made early to ensure that an adequate supply of glucagon is available 1.

Clinical Decision Making

  • It is reasonable to use a bolus of glucagon, followed by a continuous infusion, for bradycardia or hypotension due to β-blocker poisoning 1.
  • High-dose insulin therapy and vasopressors are the first line treatments, with glucagon serving as an adjunctive therapy 1.

From the Research

Glucagon as a Treatment for Beta Blocker Overdose

  • Glucagon has been used to reverse beta blocker overdose, with studies showing its effectiveness in increasing heart rate and myocardial contractility, and improving atrioventricular conduction 2, 3, 4.
  • The mechanism of action of glucagon is thought to bypass the beta-adrenergic receptor site, allowing it to be effective even in the presence of beta-receptor blocking drugs 2.
  • The recommended dose of glucagon for beta blocker overdose is 50 micrograms/kg iv loading dose, followed by a continuous infusion of 1-15 mg/h, titrated to patient response 2.

Efficacy of Glucagon in Reversing Beta Blocker Overdose

  • Studies have shown that glucagon can increase heart rate and cardiac output, and reverse second and third degree AV blocks, at least transiently, in animal models of beta blocker overdose 5.
  • However, the effect of glucagon on mean arterial pressure and survival rate in animal models of beta blocker overdose is unclear 5.
  • A randomized clinical trial found that high-dose glucagon had significant hemodynamic effects, including increased heart rate, systolic blood pressure, diastolic blood pressure, and cardiac output, regardless of beta-blockade 6.

Safety and Side Effects of Glucagon

  • Glucagon can cause side effects such as nausea, vomiting, hypokalemia, and hyperglycemia 2, 6.
  • The high cost and limited availability of glucagon may be factors precluding its future clinical acceptance 2.
  • Glucagon-induced nausea occurred in 80% of participants in a clinical trial, despite ondansetron pretreatment 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Glucagon therapy for beta-blocker overdose.

Drug intelligence & clinical pharmacy, 1984

Research

Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006

Research

Beta-blocker toxicity--the role of glucagon. Report of 2 cases.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.